Canada OKs Tavneos as Add-on Treatment for MPA and GPA

Canada OKs Tavneos as Add-on Treatment for MPA and GPA

Health Canada has approved the oral medicine Tavneos (avacopan) as an add-on therapy to treat adults with severe ANCA-associated vasculitis (AAV). The approval specifically covers the use of Tavneos to treat granulomatosis polyangiitis (GPA) and microscopic polyangiitis (MPA), the two main types of AAV, in combination with…

Love in the Time of Vasculitis

Love is such a blurry concept. It can hurt or it can heal. It can be rewarding and fulfilling and beautiful — if we know what it is. And with an autoimmune disease, love takes on an entirely different meaning. The idea of “being in love,” as most sensible…

Europe Awaits Proposed New Framework for Sharing Health Data

The European Commission is expected to propose a new governing framework for health data next month, called the European Health Data Space (EHDS), with the aim of connecting national health systems to facilitate secure and efficient transfer of data across systems in different European nations. The move is expected to…

Music as a Healthy Coping Methodology

Many people think music is a luxury. Others call it a necessity. But everyone agrees that music is enjoyable and rounds out a full life with everything the earthly and spiritual worlds have to offer. As a vasculitis patient, I’d like to add one more level of consideration. Music to…

Inflammatory Protein, PTX3, May Be Potential AAV Diagnostic Biomarker

Significantly high levels of the inflammatory protein pentraxin-3 (PTX3) were found in the bloodstream and urine of people with ANCA-associated vasculitis (AAV), particularly those with kidney involvement, a study revealed. Unlike C-reactive protein (CRP), a widely used inflammatory biomarker, PTX3 correlated with standard measures of AAV disease activity before…